By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vernalis PLC (Formerly Known As British Biotech PLC) 

Watlington Road

Oxford    OX4 5LY  United Kingdom
Phone: 01865-748747 Fax: 01865-781047



ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in anxiety and depression.

Company News
Vernalis PLC (VNLPY.PK): Notice Of Results For The Six Months Ended 30 June 2014 7/18/2014 11:03:05 AM
Vernalis PLC (VNLPY.PK) And Tris Pharma, Inc. Release: Submission Of Tuzistra™ XR (CCP-01) NDA To FDA 6/30/2014 9:15:29 AM
Vernalis PLC (VNLPY.PK) And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I 6/19/2014 9:01:10 AM
Second Product In Vernalis PLC (VNLPY.PK)' Cough Cold Pipeline Achieves Proof-Of-Concept 4/29/2014 11:16:57 AM
Vernalis PLC (VNLPY.PK): Promising Results Of Ph Ib/II POC Study In ADHD 4/24/2014 8:58:33 AM
Vernalis PLC (VNLPY.PK): Announcement of Results For Year Ended 31 Dec 2013 4/1/2014 11:08:06 AM
Vernalis PLC (VNLPY.PK) And Asahi Kasei Pharma (AHKSY.PK) Achieve Milestone 3/27/2014 10:34:55 AM
Vernalis PLC (VNLPY.PK) Announces Successful Completion Of Study 2/24/2014 9:23:00 AM
Vernalis PLC (VNLPY.PK) Announces Successful Study With CCP-01 11/25/2013 11:00:00 AM
Vernalis PLC (VNLPY.PK) Enters Into Research Collaboration 10/1/2013 10:13:36 AM